Journal
BLOOD
Volume 112, Issue 3, Pages 770-781Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2007-11-121871
Keywords
-
Categories
Funding
- NCI NIH HHS [CA94872, CA90633, R01 CA098472, R01 CA090633] Funding Source: Medline
Ask authors/readers for more resources
T-cell large granular lymphocyte (LGL) leukemia is characterized by clonal expansion of CD3+CD8+ cells. Leukemic LGLs correspond to terminally differentiated effector-memory cytotoxic T lymphocytes (CTLs) that escape Fasmediated activation-induced cell death (AICD) in vivo. The gene expression signature of peripheral blood mononuclear cells from 30 LGL leukemia patients showed profound dysregulation of expression of apoptotic genes and suggested uncoupling of activation and apoptotic pathways as a mechanism for failure of AICD in leukemic LGLs. Pathway-based microarray analysis indicated that balance of proapoptotic and antiapoptotic sphingolipid-mediated signaling was deregulated in leukemic LGLs. We further investigated sphingolipid pathways and found that acid ceramidase was constitutively overexpressed in leukemic LGLs and that its inhibition induced apoptosis of leukemic LGLs. We also showed that S1 PS is the predominant S1P receptor in leukemic LGLs, whereas S1 P1 is downregulated. FTY720, a functional antagonist of S1 P-mediated signaling, induced apoptosis in leukemic LGLs and also sensitized leukemic LGLs to Fasmediated death. Collectively, these results show a role for sphingolipidmediated signaling as a mechanism for long-term survival of CTLs. Therapeutic targeting of this pathway, such as use of FTY720, may have efficacy in LGL leukemia.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available